Granza Bio

San Francisco, United States

Granza Bio is a company that developing cancer therapies based on human body's immune system.

$7.1M raised

Jul 2024

Seed

Top Investors

Y CombinatorFelicisPioneer FundRefactorOxonian Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Granza Bio raised?

Granza Bio has raised $7.1M in total funding. The most recent round was Seed. The last funding was announced in July 2024.

Who are Granza Bio's investors?

Granza Bio's investors include Y Combinator, Felicis, Pioneer Fund, Refactor, Oxonian Ventures.

Where is Granza Bio headquartered?

Granza Bio is headquartered in San Francisco, United States.

What does Granza Bio do?

Granza Bio is a company that developing cancer therapies based on human body's immune system.

What stage is Granza Bio at?

Granza Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 3, 2024.

MLA

"Granza Bio — Funding & Investors." VCBacked, July 3, 2024, https://www.vcbacked.co/company/granza-bio. Accessed June 4, 2026.

APA

VCBacked. (2024). Granza Bio — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/granza-bio

Wikipedia (cite web)

{{cite web |title=Granza Bio — Funding & Investors |url=https://www.vcbacked.co/company/granza-bio |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 3, 2024.